2008-2023 年美国患有哮喘的老年人接种带状疱疹疫苗的趋势和特点：来自全国性自我报告调查的结果。

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2024-11-18 DOI:10.1016/j.vaccine.2024.126523

Chun-Tse Hung , Li-Min Wang , Yu-Chien Hung

{"title":"2008-2023 年美国患有哮喘的老年人接种带状疱疹疫苗的趋势和特点：来自全国性自我报告调查的结果。","authors":"Chun-Tse Hung , Li-Min Wang , Yu-Chien Hung","doi":"10.1016/j.vaccine.2024.126523","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Asthma is a risk factor for herpes zoster. However, evidence regarding herpes zoster vaccination among patients with asthma is limited. Since the recommendations and availability of herpes zoster vaccines in the U.S. have changed over time, a comprehensive investigation into herpes zoster vaccination is crucial.</div></div><div><h3>Objectives</h3><div>This study aimed to assess the trends and determinants of herpes zoster vaccination among U.S. adults with asthma aged 50 and over.</div></div><div><h3>Methods</h3><div>Data from the 2008–2023 National Health Interview Survey were used. Data were analyzed in October 2024. Joinpoint regression analysis was performed to analyze trends in herpes zoster vaccination. A multivariable logistic regression model was used to identify factors associated with herpes zoster vaccination.</div></div><div><h3>Results</h3><div>This study included 20,664 respondents, representing approximately 8.6 million U.S. adults with asthma aged 50 and over. From 2008 to 2023, a significantly increasing trend in herpes zoster vaccination was observed (average annual percent change = 13.48; 95 % CI, 9.35, 17.77; <em>P</em> < 0.01). This increasing trend was also observed when stratified by age groups. Several factors, including age, sex, race/ethnicity, region, educational level, income, asthma control, and flu vaccination, were associated with herpes zoster vaccination.</div></div><div><h3>Conclusions</h3><div>Over the past 16 years, herpes zoster vaccine coverage sharply increased among U.S. adults with asthma aged 50 and over. Disparities in several characteristics exist, underscoring the necessity for targeted policies and interventions to promote equity in herpes zoster vaccination rates.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"43 ","pages":"Article 126523"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trends and characteristics of herpes zoster vaccination among older adults with asthma in the United States, 2008–2023: Findings from self-reported national surveys\",\"authors\":\"Chun-Tse Hung , Li-Min Wang , Yu-Chien Hung\",\"doi\":\"10.1016/j.vaccine.2024.126523\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Asthma is a risk factor for herpes zoster. However, evidence regarding herpes zoster vaccination among patients with asthma is limited. Since the recommendations and availability of herpes zoster vaccines in the U.S. have changed over time, a comprehensive investigation into herpes zoster vaccination is crucial.</div></div><div><h3>Objectives</h3><div>This study aimed to assess the trends and determinants of herpes zoster vaccination among U.S. adults with asthma aged 50 and over.</div></div><div><h3>Methods</h3><div>Data from the 2008–2023 National Health Interview Survey were used. Data were analyzed in October 2024. Joinpoint regression analysis was performed to analyze trends in herpes zoster vaccination. A multivariable logistic regression model was used to identify factors associated with herpes zoster vaccination.</div></div><div><h3>Results</h3><div>This study included 20,664 respondents, representing approximately 8.6 million U.S. adults with asthma aged 50 and over. From 2008 to 2023, a significantly increasing trend in herpes zoster vaccination was observed (average annual percent change = 13.48; 95 % CI, 9.35, 17.77; <em>P</em> < 0.01). This increasing trend was also observed when stratified by age groups. Several factors, including age, sex, race/ethnicity, region, educational level, income, asthma control, and flu vaccination, were associated with herpes zoster vaccination.</div></div><div><h3>Conclusions</h3><div>Over the past 16 years, herpes zoster vaccine coverage sharply increased among U.S. adults with asthma aged 50 and over. Disparities in several characteristics exist, underscoring the necessity for targeted policies and interventions to promote equity in herpes zoster vaccination rates.</div></div>\",\"PeriodicalId\":23491,\"journal\":{\"name\":\"Vaccine\",\"volume\":\"43 \",\"pages\":\"Article 126523\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0264410X24012052\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X24012052","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

背景：哮喘是带状疱疹的危险因素：哮喘是带状疱疹的一个危险因素。然而，有关哮喘患者接种带状疱疹疫苗的证据却很有限。由于美国对带状疱疹疫苗的建议和供应情况随着时间的推移发生了变化，因此对带状疱疹疫苗接种情况进行全面调查至关重要：本研究旨在评估 50 岁及以上患有哮喘的美国成年人接种带状疱疹疫苗的趋势和决定因素：方法：采用 2008-2023 年全国健康访谈调查的数据。对 2024 年 10 月的数据进行了分析。采用连接点回归分析法分析带状疱疹疫苗接种的趋势。使用多变量逻辑回归模型确定与带状疱疹疫苗接种相关的因素：这项研究包括 20,664 名受访者，代表了约 860 万 50 岁及以上患有哮喘的美国成年人。从 2008 年到 2023 年，带状疱疹疫苗接种率呈显著上升趋势（年均百分比变化 = 13.48；95 % CI，9.35，17.77；P 结论：在过去 16 年中，带状疱疹疫苗接种率呈显著上升趋势：在过去的 16 年中，美国 50 岁及以上患有哮喘的成年人中带状疱疹疫苗的接种率急剧上升。在一些特征方面存在着差异，这说明有必要制定有针对性的政策和干预措施，以促进带状疱疹疫苗接种率的公平性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Trends and characteristics of herpes zoster vaccination among older adults with asthma in the United States, 2008–2023: Findings from self-reported national surveys

Background

Asthma is a risk factor for herpes zoster. However, evidence regarding herpes zoster vaccination among patients with asthma is limited. Since the recommendations and availability of herpes zoster vaccines in the U.S. have changed over time, a comprehensive investigation into herpes zoster vaccination is crucial.

Objectives

This study aimed to assess the trends and determinants of herpes zoster vaccination among U.S. adults with asthma aged 50 and over.

Methods

Data from the 2008–2023 National Health Interview Survey were used. Data were analyzed in October 2024. Joinpoint regression analysis was performed to analyze trends in herpes zoster vaccination. A multivariable logistic regression model was used to identify factors associated with herpes zoster vaccination.

Results

This study included 20,664 respondents, representing approximately 8.6 million U.S. adults with asthma aged 50 and over. From 2008 to 2023, a significantly increasing trend in herpes zoster vaccination was observed (average annual percent change = 13.48; 95 % CI, 9.35, 17.77; P < 0.01). This increasing trend was also observed when stratified by age groups. Several factors, including age, sex, race/ethnicity, region, educational level, income, asthma control, and flu vaccination, were associated with herpes zoster vaccination.

Conclusions

Over the past 16 years, herpes zoster vaccine coverage sharply increased among U.S. adults with asthma aged 50 and over. Disparities in several characteristics exist, underscoring the necessity for targeted policies and interventions to promote equity in herpes zoster vaccination rates.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.